← FDA Drug Approvals (Drugs@FDA)
DEXTROSE 5% AND LACTATED RINGER'S
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2022-03-28
Drug application
- FDA Application #
ANDA210332- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DEXTROSE 5% AND LACTATED RINGER'S
- Generic name
- SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE
- Active ingredients
- CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- FRESENIUS KABI USA
- Manufacturer
- Fresenius Kabi USA, LLC
- First approval
- 2022-03-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown